Clinical trial
Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate…
NCT00061867 · Imunon, Industry · Completed
Key facts
| NCT number | NCT00061867 |
|---|---|
| Title | Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer |
| Official title | A Dose Escalation, Pharmacokinetics, and Safety Study of Doxorubicin Encapsulated in Temperature Sensitive Liposomes Released Through Microwave Therapy in the Treatment of Prostate Cancer |
| Lead sponsor | Imunon, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure |
| Interventions | pegylated liposomal doxorubicin hydrochloride, hyperthermia treatment |
| Start date | Mar 1, 2003 |
| Completion | Aug 1, 2005 |
| First posted | Jun 6, 2003 |
| Last update posted | May 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: